Polysaccharide from Cyclocarya paliurus ameliorates chronic obstructive pulmonary disease through the inflammatory pathway regulated by the AhR/NF-κB pathway

Key Points

• Polysaccharide treatment significantly decreases inflammation in chronic obstructive pulmonary disease.
• A dose-dependent response shows a reduction in inflammatory cytokines by 40% in treated samples.
• Chemical analysis of polysaccharides suggests the activation of the AhR/NF-κB pathway leads to improved outcomes.
• Potential therapeutic applications for managing chronic obstructive pulmonary disease are highlighted by these findings.